Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
| Report ID | 147629 |
| Drug Identification Number | 02141019 |
| Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
| Common or Proper name | Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM GLUCONATE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mL |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-11-01 |
| Actual start date | 2021-11-01 |
| Estimated end date | 2021-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-11-16 |
| Company comments | Allocation strategy implemented to stretch inventory and ensure equitable distribution. Please see customer communication. |
| Health Canada comments | |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.